Paolo Giuseppe Bonacci

Dr. Paolo Giuseppe Bonacci

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
AMAlessia Mirabile
Alessia Mirabile
GSGiuseppe Sangiorgio
Giuseppe Sangiorgio
PBPaolo Giuseppe Bonacci
Paolo Giuseppe Bonacci
BDBivona Dalida
Bivona Dalida
ENEMANUELE NICITRA
EMANUELE NICITRA
Nicolò MussoNicolò Musso
Nicolò Musso
Digital polymerase chain reaction (dPCR) has emerged as a groundbreaking technology in molecular biology and diagnostics, offering exceptional precision and sensitivity in nucleic acid detection and quantification. This review highlights the core principles and transformative potential of dPCR, particularly in infectious disease diagnostics and environmental surveillance. Emphasizing its evolution from traditional PCR, dPCR provides accurate absolute quantification of target nucleic acids through advanced partitioning techniques. The review addresses the significant impact of dPCR in sepsis diagnosis and management, showcasing its superior sensitivity and specificity in early pathogen detection and identification of drug-resistant genes. Despite its advantages, challenges such as optimization of experimental conditions, standardization of data analysis workflows, and high costs are discussed. Furthermore, we compare various commercially available dPCR platforms, detailing their features and applications in clinical and research settings. Additionally, the review explores dPCR’s role in water microbiology, particularly in wastewater surveillance and monitoring of waterborne pathogens, underscoring its importance in public health protection. In conclusion, future prospects of dPCR, including methodological optimization, integration with innovative technologies, and expansion into new sectors like metagenomics, are explored.

Verified
Journal Article
Open access
PDF file
GSGiuseppe Sangiorgio
Giuseppe Sangiorgio
ENEMANUELE NICITRA
EMANUELE NICITRA
BDBivona Dalida
Bivona Dalida
CBCarmelo Bonomo
Carmelo Bonomo
PBPaolo Bonacci
Paolo Bonacci
SSStefania Stefani
Stefania Stefani
Extracellular vesicles (EVs) are lipid bilayers derived from cell membranes, released by both eukaryotic cells and bacteria into the extracellular environment. During production, EVs carry proteins, nucleic acids, and various compounds, which are then released. While Gram-positive bacteria were traditionally thought incapable of producing EVs due to their thick peptidoglycan cell walls, recent studies on membrane vesicles (MVs) in Gram-positive bacteria have revealed their significant role in bacterial physiology and disease progression. This review explores the current understanding of MVs in Gram-positive bacteria, including the characterization of their content and functions, as well as their interactions with host and bacterial cells. It offers a fresh perspective to enhance our comprehension of Gram-positive bacterial EVs.

12 December 2022 in Translational Oncology
Verified
Journal Article
Open access
PBPaolo G. Bonacci
Paolo G. Bonacci
Giuseppe CarusoGiuseppe Caruso
Giuseppe Caruso
GSGrazia Scandura
Grazia Scandura
CPClarissa Pandino
Clarissa Pandino
ARAlessandra Romano
Alessandra Romano
NMNicolò Musso
Nicolò Musso
• DEP is an electrokinetic approach for discriminating and separating floating cells. • Buffer composition differently influence the viability of Caco-2 and K562 cells. • NaCl concentration influences both Flow Cytometry outcomes and cell size. • Buffer composition differently influences cell parameters in Caco-2 and K562 cells. • Buffer composition differently influences gene expression in Caco-2 and K562 cells.

30 August 2022 in Cancers
Verified
Journal Article
Open access
PDF file
Giorgio Ivan RussoGiorgio Ivan Russo
Giorgio Ivan Russo
PBPaolo Bonacci
Paolo Bonacci
BDBivona Dalida
Bivona Dalida
Grete Francesca PriviteraGrete Francesca Privitera
Grete Francesca Privitera
Giuseppe BroggiGiuseppe Broggi
Giuseppe Broggi
Nicolò MussoNicolò Musso
Nicolò Musso
Background: Prostate cancer (PCa) is a disease with a wide range of clinical manifestations. Up to the present date, the genetic understanding of patients with favorable or unfavorable prognosis is gaining interest for giving the appropriate tailored treatment. We aimed to investigate genetic changes associated with lymph node metastasis in a cohort of hormone-naïve Pca patients. Methods: We retrospectively analyzed data from 470 patients who underwent surgery for PCa between 2010 and 2020 at the Department of Urology, University of Catania. Inclusion criteria were patients with lymph node metastasis and patients with PCa with extra capsular extension (pT3) and negative lymph node metastasis. The final cohort consisted of 17 different patients (11 PCa with lymph node metastasis and 6 PCa without lymph node metastasis). Through the cBioPortal online tool, we analyzed gene alterations and their correlations with clinical factors. Results: A total of 688 intronic, synonym and nonsynonym mutations were sequenced. The gene with the most sequenced mutations was ERBB4 (83 mutations, 12% of 688 total), while the ones with the lower percentage of mutations were AKT1, FGFR2 and MLH1 (1 mutation alone, 0.14%). Conclusion: In the present study we found mostly concordance concerning the ERBB4 mutation between both primary PCa samples and matched lymph node metastasis, underlining that the identification of alterations in the primary tumor is extremely important for cancer prognosis prediction.

3 June 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
BDBivona Dalida
Bivona Dalida
AMAlessia Mirabile
Alessia Mirabile
CBCarmelo Bonomo
Carmelo Bonomo
PBPaolo Giuseppe Bonacci
Paolo Giuseppe Bonacci
Stefano StracquadanioStefano Stracquadanio
Stefano Stracquadanio
Dafne BongiornoDafne Bongiorno
Dafne Bongiorno
The World Health Organization has identified antimicrobial resistance as a public health emergency and developed a global priority pathogens list of antibiotic-resistant bacteria that can be summarized in the acronym ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacterales species), reminding us of their ability to escape the effect of antibacterial drugs. We previously tested new heteroaryl-ethylene compounds in order to define their spectrum of activity and antibacterial capability. Now, we focus our attention on PB4, a compound with promising MIC and MBC values in all conditions tested. In the present study, we evaluate the activity of PB4 on selected samples of ESKAPE isolates from nosocomial infections: 14 S. aureus, 6 E. faecalis, 7 E. faecium, 12 E. coli and 14 A. baumannii. Furthermore, an ATCC control strain was selected for all species tested. The MIC tests were performed according to the standard method. The PB4 MIC values were within very low ranges regardless of bacterial species and resistance profiles: from 0.12 to 2 mg/L for S. aureus, E. faecalis, E. faecium and A. baumannii. For E. coli, the MIC values obtained were slightly higher (4–64 mg/L) but still promising. The PB4 heteroaryl-ethylenic compound was able to counteract the bacterial growth of both high-priority Gram-positive and Gram-negative clinical strains. Our study contributes to the search for new molecules that can fight bacterial infections, in particular those caused by MDR bacteria in hospitals. In the future, it would be interesting to evaluate the activity of PB4 in animal models to test for its toxicity.

25 August 2021 in Antibiotics
Verified
Journal Article
Open access
PDF file
Dafne BongiornoDafne Bongiorno
Dafne Bongiorno
Nicolò MussoNicolò Musso
Nicolò Musso
PBPaolo G. Bonacci
Paolo G. Bonacci
BDBivona Dalida
Bivona Dalida
MMMariacristina Massimino
Mariacristina Massimino
SSStefania Stefani
Stefania Stefani
The widespread use of antibiotics has led to a gradual increase in drug-resistant bacterial infections, which severely weakens the clinical efficacy of antibacterial therapies. In recent decades, stilbenes aroused great interest because of their high bioavailability, as well as their manifold biological activity. Our research efforts are focused on synthetic heteroaromatic stilbene derivatives as they represent a potentially new type of antibiotic with a wide antibacterial spectrum. Herein, a preliminary molecular modeling study and a versatile synthetic scheme allowed us to define eight heteroaromatic stilbene derivatives with potential antimicrobial activity. In order to evaluate our compound’s activity spectrum and antibacterial ability, minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) tests have been performed on Gram-positive and Gram-negative ATCC strains. Compounds PB4, PB5, PB7, and PB8 showed the best values in terms of MIC and were also evaluated for MBC, which was found to be greater than MIC, confirming a bacteriostatic activity. For all compounds, we evaluated toxicity on colon-rectal adenocarcinoma cells tumor cells (CaCo2), once it was established that the whole selected set was more active than 5-Fluorouracil in reducing CaCo-2 cells viability. To the best of our knowledge, the biological assays have shown for these derivatives an excellent bacteriostatic activity, compared to similar molecular structures previously reported, thus paving the way for a new class of antibiotic compounds.